EU unveils measures to combat biopiracy

EU headquarters are pictured in Brussels in 2005. The European Union on Thursday set out proposals aimed at thwarting the illegal use of genetic resources and traditional medicine, a practice known as biopiracy.

The European Union on Thursday set out proposals aimed at thwarting the illegal use of genetic resources and traditional medicine, a practice known as bio-piracy.

A Europe-wide regulation would create "a level playing field for all users of genetic resources," the European Commission said in a press release that coincided with a UN conference on biodiversity in Hyderabad, India.

Developing countries, led by India, are complaining that pharmaceutical and cosmetic firms are using local species of in their research or exploiting for their own gain.

Confusion on how genetic treasures and knowledge should be shared led in 2010 to the Nagoya Protocol, which members of the UN (CBD) have pledged to pass into their national laws.

The draft EU regulation would require users to declare they have exercised "due diligence" in meeting the legal requirements in the country of origin and in showing that the benefits are "fairly and equitably shared," the commission said.

As part of the initiative, an EU database of "trusted collections" of seed banks and botanical gardens will be set up to inform users about the origins of .

The proposed measures will be put to the and the Council of Ministers, the 27-nation bloc's highest decision-making body.

More than a quarter of all approved drugs over the past 30 years are either natural products or have been derived from a natural product, the commission said.

The CBD meeting runs in Hyderabad until October 19, climaxing in a three-day meeting of environment ministers on a plan to roll back biodiversity decline by 2020.

Related Stories

EU agrees crack down on shark finning

date Mar 19, 2012

The European Union endorsed tighter shark fishing rules on Monday to ensure fishermen respect a ban on slicing off the fins of their catches and throwing the live body overboard to drown.

Recommended for you

Cardinal Health paying $26.8 million in FTC settlement

date 20 hours ago

Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.

Selecting the right tool for the job

date Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.